IRDOpus Genetics, Inc.
$4.65+127% 1Y
$4.65
$1.7452 weeks$6.09
Is the price fair?
What IRD's price assumes
Opus Genetics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 31.4× revenue.
31.4
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 26.4
EV / sales
Details›
- EV / EBIToperating margin −513%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 26.4
- Market capitalisation
- $367M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.